pharma · Inflammatory Bowel Disease (IBD) · Melanoma · IRON
Disc Medicine
Disc Medicine is a pharma organization headquartered in Watertown, USA. It trades on NYSE under ticker IRON. Primary therapeutic focus areas include Inflammatory Bowel Disease (IBD), Melanoma, Parkinson's disease, Falcip
Company details
- Status
- Public
- HQ
- 321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
- Employees
- 165
- Programs
- 308
- Drugs
- 443
- Patents
- 706
202100617
Phase 3 · small molecule · Combined endpoint of all-cause mortality, kidney failure, and hospitalization for heart failure in the overall study population
202100617 for Combined endpoint of all-cause mortality, kidney failure, and hospitalization for heart failure in the overall study population is a Phase 3 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Internal code 202100617
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Disc Medicine
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Combined endpoint of all-cause mortality, kidney failure, and hospitalization for heart failure in the overall study population
- Status
- active
- Trials
- 1